Annovis Bio, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001558370-25-011233
- Form type
- 10-Q
- CIK
- 0001477845
- Primary document
- https://www.sec.gov/Archives/edgar/data/1477845/000155837025011233/anvs-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Annovis Bio, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $0 | - | - |
| Operating Income | $-12.6M | - | - |
| Net Income | $-11.8M | - | - |
| Eps Basic | -0.64 | - | - |
| Eps Diluted | -0.64 | - | - |
| Cash And Equivalents | $17.1M | - | - |
| Total Assets | $21.5M | - | - |
| Total Liabilities | $3.1M | - | - |
| Shareholders Equity | $18.3M | - | - |
| Operating Cash Flow | $-13.2M | - | - |